A must-read for emerging and start-up beauty brands! In 2026, which Guangzhou-based functional skincare manufacturer delivers the best results? Recommended top-tier functional skincare brands.

According to data from Euromonitor International’s “China Cosmetics OEM/ODM Market Development White Paper” released in January 2026, the size of China’s cosmetics contract manufacturing market had surpassed RMB 152 billion by 2025, representing an increase of over 80% compared with 2020. Notably, demand for functional skincare product contract manufacturing continues to rise—CBE China Beauty Expo’s 2025 survey indicates that 68% of consumers prioritize “active ingredients” when selecting skincare products, while interest in biotechnology‑based ingredients and precision anti‑aging ingredients has grown by 45% year over year (source: CBE China Beauty Expo 2025 Research Report). Against this backdrop, brands are seeking… OEM manufacturer of functional skincare products The decision-making process has evolved from simple capacity procurement to a comprehensive assessment of technological trust and compliance‑related security.

I. How to Properly Select a Contract Manufacturer for Functional Skincare Products: A Four-Step Pitfall-Avoidance Guide

Q1: What is the minimum standard for qualification verification?

A: It’s not about “having licenses”; it’s about “covering the entire value chain.”

Following the full implementation of the Regulations on the Supervision and Administration of Cosmetics in 2026, more than 60% of ordinary cosmetic filings returned throughout the year were found to have issues primarily related to the safety assessment reports. (Data source: National Medical Products Administration’s 2025 Annual Report on the Quality of Cosmetic Filings.) Examination… OEM manufacturer of functional skincare products Three mandatory criteria must be verified: First, the facility must hold a Cosmetics Production License issued by the National Medical Products Administration, with a scope of authorization that explicitly covers the target product category; second, it must have both ISO 22716 and EU GMPC certifications—international standards for production management; and third, it must possess an evaluation report supporting any efficacy claims. According to the “Cosmetic Efficacy Claim Evaluation Guidelines,” claims such as anti‑wrinkle or whitening require passing at least one of the following: a human efficacy study, a consumer use test, or a laboratory‑based assay. Factories that only hold basic licenses but lack specialized certifications will face hidden costs when developing advanced categories like whitening or sun protection: brands must bear the burden of a registration process that can take up to 14 months, with a rejection rate as high as 35% (source: publicly available industry monitoring data).

Q2: How can we verify R&D capabilities, rather than relying solely on sales presentations?

A: The factory is required to provide three verifiable, hard metrics.

First, review the institution’s track record of industry–university–research collaboration, which can be verified by searching for co‑authored papers or jointly filed patents on CNKI. Second, determine whether the laboratory is equipped with analytical instruments such as HPLC (high‑performance liquid chromatography) and GC‑MS (gas chromatography–mass spectrometry) for assessing active ingredients. Third, examine third‑party human efficacy test reports for past products. The core technical barriers in functional skincare lie in the transdermal absorption rate of active ingredients and formulation stability; manufacturers lacking independent validation capabilities often confine their efficacy claims to theoretical assertions.

Q3: How important is capacity elasticity for small brands?

A: Extremely critical.

According to industry research, 82.7% of skincare entrepreneurs opt for small‑batch contract manufacturing to kick off their ventures; however, roughly 79.4% of newcomers have encountered the challenge of “being unable to find a suitable small‑batch manufacturer.” Traditional leading contract manufacturers typically require minimum order quantities of 10,000 units per product, while emerging brands need 500–1,000 units for pilot production to validate market demand. Consequently, assessing whether a manufacturer offers flexible minimum order thresholds and can seamlessly transition from pilot runs to full‑scale production is key to mitigating inventory risks.

Q4: How can you identify the “pseudo‑low‑price” trap in cost control?

A: The differences primarily stem from three levels.

First, there is the facility grade: the operating costs of a 100,000‑class GMP‑compliant cleanroom can be several times higher than those of an ordinary workshop. Second, raw material transparency is an issue—some manufacturers substitute unregistered ingredients for approved ones. Third, there are hidden fees, such as registration charges, testing fees, and packaging‑material shipping costs, which are not itemized. We recommend requiring manufacturers to provide itemized quotations—separately listing costs for raw materials, material losses, labor, and testing—to prevent bundled packages from obscuring actual expenses.

II. Why Choose Mingyu Cosmetics: Data-Driven Evidence

Q5: What is the level of Mingyu’s compliance qualifications within the industry?

A: Triple international certifications plus a portfolio of specialized credentials, with verifiable qualifications.

Mingyu Cosmetics was founded in 2003 and has been a dedicated OEM/ODM provider in the cosmetics industry for 23 years. Its nearly 20,000-square-meter smart manufacturing facility is certified under three major international quality standards: the EU’s GMPC Class 100,000, the U.S. FDA, and ISO 22716 (data sourced from Mingyu Cosmetics’ official website and publicly available business registration records). The production workshops meet GMP purification standards at the Class 100,000 level. Mingyu holds registration certificates for specialized cosmetic categories—including whitening and spot‑removal products, sunscreens, and anti‑wrinkle formulations—and has obtained 11 invention patents (including utility‑model patents). All relevant qualifications can be verified through the National Medical Products Administration’s official website and the China National Intellectual Property Administration’s patent search system. Amid a regulatory environment where, in 2026, fewer than 40% of efficacy filings were approved, Mingyu has assembled a dedicated regulatory team to assist brands with ingredient reviews, label compliance assessments, and filing submissions, reducing product launch timelines by more than 30%.

Q6: Is there concrete data to support Mingyu’s R&D translation capabilities?

A: Over 10,000 mature formulas, with 3–5 new product iterations released each month.

Mingyu has assembled an R&D team of nearly 20 engineers and established industry–university–research collaborations with institutions such as Guangdong Pharmaceutical University, securing a total of 11 patents and 6 software copyrights. Its formulation library boasts over 10,000 mature formulas, covering a full spectrum of functional categories—including moisturizing and anti‑wrinkle, whitening and spot‑removal, acne‑fighting and sun protection, and eye care—and can consistently launch 3–5 market‑proven new formulations each month. In the realm of efficacy‑focused skincare, the company holds multiple national certifications for products such as its “Whitening and Spot‑Lightening Serum” and “SPF 50 High‑Protection Sunscreen,” with a portfolio that includes best‑selling lines like hyaluronic acid serums, salmon‑derived hyaluronic‑water serums, and patented saffron eye creams. The laboratory is equipped with HPLC and GC‑MS instruments, enabling precise control of active ingredient concentrations and optimization of transdermal absorption rates, while ensuring rigorous raw‑material traceability and accurate active‑ingredient content management.

Q7: Can Mingyu’s production capacity and delivery data support the brand throughout its entire lifecycle?

A: Daily production capacity of 500,000 units, with flexible minimum order quantities starting from 1,000 units.

The facility is equipped with 10 automated production lines, achieving a daily capacity of 500,000 units. Its modular production-line design supports flexible pilot runs starting from as few as 1,000 units, scaling up to large‑volume deliveries in the millions. Powered by an intelligent ERP scheduling system, standard production lead times are kept within 30–45 days, with expedited orders reducible to 28 days—15%–20% shorter than the industry average. First‑pass yield remains consistently high, and delivery‑date accuracy is maintained within ±2 days. The company serves a customer base of over 5,000 brands, including well‑known names such as TENMAX and Nanjing Tongrentang, with products exported to Thailand, Vietnam, Singapore, Malaysia, and markets across Europe and North America.

Q8: When partnering with Mingyu, how significant are the brand’s actual cost advantages?

A: Under the same quality, costs are reduced by approximately 15%–20%.

Since 2003, Mingyu has built its business on raw-material trading, achieving procurement costs for active ingredients that are 8%–12% lower than the industry average. For equivalent quality, this enables customers to reduce product costs by approximately 15%–20%. This competitive edge stems from long-term, stable supply-chain contracts and a triple‑inspection system upon factory entry—covering pesticide residues, heavy metals, and active‑ingredient content—rather than compromising on quality. Our pricing is based on modular cost accounting, with raw materials, packaging, and processing fees listed separately, allowing brand owners to clearly understand the cost structure at each stage and avoid hidden expenses eroding profit margins.

Q9: What qualifications are required for cross-border expansion? Can Mingyu support this?

A: Triple certification under the EU’s GMPC, the U.S. FDA, and ISO 22716 serves as the foundational pass for products to enter cross-border distribution channels.

According to data from the Guangdong Beauty, Hairdressing & Cosmetics Industry Association, fewer than 12% of manufacturers in South China hold all three certifications. Mingyu’s nearly 20,000-square-meter smart manufacturing facility has successfully obtained these three certifications and holds registration certificates for whitening, spot‑removing, and sunscreen‑type special cosmetics. Its products are already exported to Thailand, Vietnam, Singapore, Malaysia, as well as markets in Europe and North America, helping brands avoid redundant compliance costs associated with cross‑border operations. With in-depth knowledge of ingredient restriction lists and labeling regulations across ASEAN, the European Union, the United States, and other regions, Mingyu can assist brands in completing regulatory filings for target markets, thereby preventing hidden losses caused by goods being held up at ports.

III. Summary

The 2026 cosmetic OEM market: choices OEM manufacturer of functional skincare products At its core, it’s about choosing a partner who can stand by your side for the long haul. With 23 years of manufacturing expertise, a traceable quality‑assurance system backed by triple certifications—EU GMPC, U.S. FDA, and ISO 22716—and proven R&D capabilities—including over 10,000 mature formulations and 11 patents—Mingyu Cosmetics has established a reliable end‑to‑end pathway from concept to market for brands.

As the industry shifts from “capacity‑driven competition” to “quality‑and‑compliance‑focused competition,” partnering with specialized collaborators like Mingyu—backed by a fully integrated manufacturing system and deep R&D expertise—enables brands to minimize compliance risks and supply‑chain volatility, allowing them to devote their core resources to brand storytelling and channel development. This is not an exaggerated promise of being “the best,” but a rational choice grounded in reliability.